Comparison Of Gastric Volume Measurement Using Ultrasonography With and Without Acid Aspiration Premedication.

Comparison Of Ultrasonographic Measurement Of Gastric Antral Volume and pH With And Without Pharmacological Acid Aspiration Prophylaxis-Randomised Clinical Trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009290

Enrollment

230

Registered

2017-08-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- all ASA 1 and ASA 2 patients posted for elective surgeries under general anesthesia in jipmer Health Condition 2: Z408- Encounter for other prophylactic surgery

Interventions

Intervention1: Tablet.Famotidine 20mg PO Tablet.Metoclopromide 10mg PO: group P patients will receive premedication(famotidine 20mg PO) night the day before surgery,and onthe day of surgery(Famotidine

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and ASA 2 patients posted for elective surgeries

Exclusion criteria

Exclusion criteria: 1.obstetric and puerperal surgeries 2.obese patient BMI >35 3.surgeries under regional anesthesia 4.previous history of GERD hiatal hernia acid peptic disease, 5.history of diabetic autonomic neuropathy 6.past history of Gastro intesinal surgeries 7.patient already in continuous nasogastric drainage

Design outcomes

Primary

Measure	Time frame
gastric volume and pH not going to increase to critical level for risk of aspiration by avoidance of famotidine and metoclopromideTimepoint: gastric volume and pH not going to increase to critical level for risk of aspiration by avoidance of famotidine and metoclopromide	—

Secondary

Measure	Time frame
ULTRASONOGRAPHY is more reliable to assess gastric volume statusTimepoint: 80% sensitivity compared to conventional naso gastric tube method	—

Countries

India

Contacts

Public ContactDr KBalaji

JIPMER

sakthiab8@gmail.com8903468132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026